Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
ITGAM Biologics Sequence Review Report 2026: Integrin alpha-M Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGAM protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FGF7 Biologics Sequence Review Report 2026: Fibroblast growth factor 7 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FGF7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL11 Biologics Sequence Review Report 2026: Interleukin-11 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXCL3 Biologics Sequence Review Report 2026: C-X-C motif chemokine 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCL3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CXCL2 Biologics Sequence Review Report 2026: C-X-C motif chemokine 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CXCL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
IL1RN Biologics Sequence Review Report 2026: Interleukin-1 receptor antagonist protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of IL1RN protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD7 Biologics Sequence Review Report 2026: T-cell antigen CD7 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD48 Biologics Sequence Review Report 2026: CD48 antigen Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD48 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
ITGA5 Biologics Sequence Review Report 2026: Integrin alpha-5 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGA5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
ITGA2B Biologics Sequence Review Report 2026: Integrin alpha-IIb Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of ITGA2B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD3E Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD3 epsilon chain Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD3E protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD160 Biologics Sequence Review Report 2026: CD160 antigen Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD160 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
193
194
195
196
197
>>
1503
>